Digital imaging systems manufacturer Vision Research has supplied the Phantom VEO 710 high-speed camera for use in Cytovale’s IntelliSep test.
The IntelliSep test has been designed to help clinicians with the early detection of sepsis probability.
It provides test results in less than ten minutes and supports critical, time-sensitive clinical decisions.
Recently, Cytovale’s diagnostic tool received 510(k) clearance from the US Food and Drug Administration (FDA).
Vision Research’s Phantom VEO 710 high-speed camera captures images at more than seven Gpx/second.
The VEO camera resolves blood cells as they move at three meters per second through the microfluidics channel, which requires frame rates of more than 500,000 frames per second (fps).
The VEO 710 uses a custom CMOS sensor and supports quick data offload, which contributes to IntelliSep’s quick, ten-minute sample turnaround time.
It is designed to perform in environments that experience shock, vibration and extreme temperatures to ensure long-term reliability.
Vision Research claims that the Phantom VEO 710 is a well-established camera that is used in various industries and applications.
Vision Research product manager Toni Lucatorto said: “Phantom VEO high-speed cameras provide valuable insights into many biological and biomedical events that are otherwise too fast to be seen.
“They are a key enabling technology in flow cytometry, and we’re very excited to be part of this life-saving medical breakthrough.”
The VEO body is available in the L (light) and S (full) models.
The L-model is often found in labs or offices, while the S-model adds various options that increase durability and flexibility.
Vision Research designs and manufactures a range of digital high-speed imaging systems that are used in several applications.